XML 27 R11.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT INFORMATION
 9 Months Ended
Jun. 30, 2019
SEGMENT INFORMATION  
SEGMENT INFORMATION

5.    SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies and other clients. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10‑K for the fiscal year ended September 30, 2018.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

June 30, 

 

June 30, 

 

    

2019

    

2018

    

2019

    

2018

Revenue:

 

 

  

 

 

  

 

 

  

 

 

  

Service

 

$

9,689

 

$

4,866

 

$

25,555

 

$

14,421

Product

 

 

1,172

 

 

1,173

 

 

3,275

 

 

2,939

 

 

$

10,861

 

$

6,039

 

$

28,830

 

$

17,360

Operating Income (Loss)

 

 

  

 

 

  

 

 

  

 

 

  

Service

 

$

1,385

 

$

582

 

$

2,899

 

$

2,280

Product

 

 

23

 

 

125

 

 

(27)

 

 

210

Corporate

 

 

(1,659)

 

 

(739)

 

 

(3,529)

 

 

(2,401)

 

 

$

(250)

 

$

(32)

 

$

(657)

 

$

89

 

 

 

  

 

 

  

 

 

  

 

 

  

Interest expense

 

 

(178)

 

 

(49)

 

 

(426)

 

 

(149)

Other income

 

 

 2

 

 

 1

 

 

 5

 

 

 5

Loss before income taxes

 

$

(426)

 

$

(80)

 

$

(1,078)

 

$

(55)